Tradenames starting with "E"

Patents whose numbers are in italics have been extended under 35 USC 156. All expiration dates include applicable Sec. 156 and pediatric (PED) extensions.
Products tagged as [GENERIC] have had a generic equivalent approved for at least one strength of the product.


EPIPEN; EPIPEN JR. (INJECTABLE) (INTRAMUSCULAR, SUBCUTANEOUS) EPINEPHRINE [GENERIC AB]
NDA Applicant: MYLAN SPECIALITY LP      NDA No.:
019430  Prod. No.: 001 RX (0.3MG/DELIVERY); 002 RX (0.15MG/DELIVERY)
PatentsExpirationPatented Use
Pat. No. 7449012 DP* Automatic injector
Claim Types: Device
Pat. Sub. Date(s): All strengths: None
Sep 11, 2025 
Pat. No. 7794432 DP* Automatic injector with kickback attenuation
Claim Types: Device; Process
Pat. Sub. Date(s): All strengths: None
Sep 11, 2025 
Pat. No. 8048035 DP* Automatic injector with needle cover
Claim Types: Device
Pat. Sub. Date(s): 001: Nov 25, 2011; 002: None
Sep 11, 2025 
Pat. No. 9586010 DP* Automatic injector with needle cover
Claim Types: Device
Pat. Sub. Date(s): All strengths: May 12, 2017
Sep 11, 2025 

DS*=Drug Substance and DP*=Drug Product: patent submitted for the product after Aug. 18, 2003.
Last edited: 18 November 2023
© 2001-2023 Bruce A. Pokras, All rights reserved worldwide